Table 2.
Characteristics | n | Risk score | P-value | |
---|---|---|---|---|
Low | High | |||
Total Cases | 601 | 301 | 300 | |
Age | ||||
<49 | 320 | 211 | 109 | <0.0001 |
≥49 | 281 | 90 | 191 | |
Gender | ||||
Male | 351 | 178 | 173 | 0.7774 |
Female | 250 | 123 | 127 | |
Grade | ||||
II | 211 | 168 | 43 | <0.0001 |
III | 236 | 131 | 105 | |
IV | 154 | 2 | 152 | |
Subtype | ||||
Neural | 36 | 19 | 17 | <0.0001 |
Proneural | 381 | 279 | 102 | |
Classical | 149 | 3 | 146 | |
Mesenchymal | 35 | 0 | 35 | |
IDH status | ||||
Mutant | 374 | 293 | 81 | <0.0001 |
Wildtype | 227 | 8 | 219 | |
1p/19q status | ||||
Codel | 149 | 142 | 7 | <0.0001 |
Non-codel | 223 | 150 | 73 | |
NA | 229 | 9 | 220 | |
MGMT promoter status | ||||
Unmethylated | 147 | 20 | 127 | <0.0001 |
Methylated | 420 | 281 | 139 | |
NA | 34 | 0 | 34 | |
EGFR status | ||||
Amplification | 106 | 1 | 105 | <0.0001 |
No amplification | 487 | 298 | 189 | |
NA | 8 | 2 | 6 |
Statistical significance is shown in bold.